Optimi Health Corp. (OPTH) Form 424B3 — Aug 27, 2026
Optimi Health Corp. filed a 424B3 prospectus registering up to 21,943,260 common shares for resale by Seven Knots, LLC under an August 13, 2026 purchase agreement, a block equal to roughly 383.2% of Optimi's total shares outstanding. The structure lets Optimi elect to sell shares to Seven Knots over time for up to $100 million in aggregate gross proceeds, with Seven Knots reselling at market prices and keeping all resale proceeds. As consideration, Seven Knots received a $1.5 million non-interest-bearing convertible commitment note, plus a $500,000 note that is triggered once sales under the agreement reach $7 million, with conversion sized at a $3.00 floor price.
Key figures
- Floor Price Usd
- 3
- Funding Runway
- approximately 12 months
- Commitment Shares
- 666667
- Max Purchase Shares
- 21276593
- Cse Price Aug25 2026
- C$6.83
- Fse Price Aug25 2026
- EUR 4.25
- Assumed Share Price Usd
- 4.68
- Nasdaq Price Aug25 2026
- 4.9
- Net Loss Fiscal Year2025
- C$3,712,031 (US$2,665,349)
- Initial Commitment Note Usd
- 1500000
- Shares Registered For Resale
- 21943260
- Percent Of Shares Outstanding
- 383.2%
- Additional Commitment Note Usd
- 500000
- Accumulated Deficit Jun30 2026
- C$31,360,001 (US$22,076,734)
- Max Aggregate Gross Proceeds Usd
- 100000000
- Additional Note Trigger Proceeds
- $7 million
- Net Loss Nine Months Ended Jun30 2026
- C$5,552,091 (US$3,147,661)
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.